The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Shakeel, K.,
Olamendi-Portugal, T.,
Naseem, M. U.,
Becerril, B.,
Zamudio, F. Z.,
Delgado-Prudencio, G.,
Possani, L. D.,
Panyi, G.:
Characterization of seven new K+ channel blocker peptides of Centruroides bonito revealed that α-KTx 2.24 has a picomolar affinity for Kv1.2.
Biophys. J. 124 (3), 602a, 2025.
Shakeel, K.,
Naseem, M. U.,
Olamendi-Portugal, T.,
Zamudio, F. Z.,
Possani, L. D.,
Panyi, G.:
Cvill6 and Cvill7: Potent and Selective Peptide Blockers of Kv1.2 Ion Channel Isolated from Mexican Scorpion Centruroides villegasi.
Toxins. 17 (6), 1-19, (article identifier: 279), 2025.
Sanches, K.,
Ashwood, L. M.,
Olushola-Siedoks, A. A. M.,
Wai, D. C. C.,
Rahman, A.,
Shakeel, K.,
Naseem, M. U.,
Panyi, G.,
Prentis, P.,
Norton, R. S.:
Structure-function relationships in domain peptides: from the sea anemone.
Proteins. 92 (2), 192-205, 2024.
Naseem, M. U.,
Gurrola-Briones, G.,
Romero-Imbachi, M. R.,
Borrego, J.,
Carcamo-Noriega, E.,
Beltrán-Vidal, J.,
Zamudio, F. Z.,
Shakeel, K.,
Possani, L. D.,
Panyi, G.:
Characterization and Chemical Synthesis of Cm39 (α-KTx 4.8): a Scorpion Toxin That Inhibits Voltage-Gated K+ Channel KV1.2 and Small- and Intermediate-Conductance Ca2+-Activated K+ Channels KCa2.2 and KCa3.1.
Toxins. 15 (1), 1-21, (article identifier: 41), 2023.
Shakeel, K.,
Olamendi-Portugal, T.,
Naseem, M. U.,
Becerril, B.,
Zamudio, F. Z.,
Delgado-Prudencio, G.,
Possani, L. D.,
Panyi, G.:
Of Seven New K<U+009a> Channel Inhibitor Peptides of Centruroides bonito, α-KTx 2.24 Has a Picomolar Affinity for Kv1.2.
Toxins. 15 (8), 1-20, (article identifier: 506), 2023.
Borrego, J.,
Naseem, M. U.,
Sehgal, A. N. A.,
Panda, L. R.,
Shakeel, K.,
Gáspár, A.,
Nagy, C.,
Varga, Z.,
Panyi, G.:
Recombinant Expression in Pichia pastoris System of Three Potent Kv1.3 Channel Blockers: Vm24, Anuroctoxin, and Ts6.
J. Fungi. 8 (11), 1-15, (article identifier: 1215), 2022.